IRIS
VOSO, MARIA TERESA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.569
EU - Europa 1.265
AS - Asia 419
SA - Sud America 39
OC - Oceania 25
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.335
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.506
FR - Francia 339
IT - Italia 320
DE - Germania 316
CN - Cina 188
GB - Regno Unito 69
IN - India 59
JP - Giappone 53
CA - Canada 47
NL - Olanda 37
ES - Italia 27
BR - Brasile 25
AU - Australia 24
IE - Irlanda 23
SE - Svezia 22
VN - Vietnam 22
CH - Svizzera 18
ID - Indonesia 14
RU - Federazione Russa 13
TW - Taiwan 13
CZ - Repubblica Ceca 12
FI - Finlandia 12
RO - Romania 11
SG - Singapore 11
TR - Turchia 11
AE - Emirati Arabi Uniti 10
MX - Messico 9
KR - Corea 8
ZA - Sudafrica 8
UA - Ucraina 7
DK - Danimarca 6
HK - Hong Kong 6
IL - Israele 6
CL - Cile 5
GR - Grecia 5
PT - Portogallo 5
AR - Argentina 4
AT - Austria 4
HU - Ungheria 4
MO - Macao, regione amministrativa speciale della Cina 4
PL - Polonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
MA - Marocco 3
PK - Pakistan 3
AL - Albania 2
AW - Aruba 2
BE - Belgio 2
EG - Egitto 2
HR - Croazia 2
IQ - Iraq 2
IR - Iran 2
LB - Libano 2
PE - Perù 2
SV - El Salvador 2
TH - Thailandia 2
CO - Colombia 1
EU - Europa 1
IS - Islanda 1
LY - Libia 1
MK - Macedonia 1
MQ - Martinica 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.335
Salva come PNG Salva come JPEG
Città #
Woodbridge 152
Houston 138
Fairfield 114
Santa Cruz 103
Ashburn 97
Rome 97
Buffalo 69
Seattle 67
Wilmington 61
Paris 42
Ann Arbor 40
Cambridge 37
Chicago 28
Milan 26
Boston 24
Shanghai 24
Beijing 23
Dublin 21
San Diego 20
Mountain View 19
Guangzhou 18
Nürnberg 17
Stockholm 15
Ottawa 14
Hanoi 13
Chengdu 12
Hangzhou 12
Los Angeles 12
São Paulo 12
Tokyo 12
New York 11
Philadelphia 11
Duncan 10
Jakarta 10
Vancouver 9
Dong Ket 8
Helsinki 8
Toronto 8
University Park 8
Boardman 7
Cedar Knolls 7
Chennai 7
Clearwater 7
Council Bluffs 7
Dallas 7
Henderson 7
Leawood 7
Leipzig 7
London 7
Nanjing 7
Bologna 6
Las Vegas 6
Lubbock 6
Naples 6
Osaka 6
Suzhou 6
Taipei 6
Atlanta 5
Bengaluru 5
Jaipur 5
Karlsruhe 5
Montemarciano 5
Muizenberg 5
Portland 5
Saint Petersburg 5
Utrecht 5
Zhengzhou 5
Amsterdam 4
Beaverton 4
Bucharest 4
Changchun 4
Columbus 4
Dearborn 4
Etobicoke 4
Jacksonville 4
Macao 4
Montesilvano Marina 4
Parma 4
Saint Louis 4
San Jose 4
Visakhapatnam 4
Washington 4
Ankara 3
Bern 3
Budapest 3
Büdelsdorf 3
Cernobbio 3
Charlestown 3
Cleveland 3
Frankfurt Am Main 3
Guzmán 3
Herndon 3
Mainz 3
Messina 3
Miami 3
Moscow 3
Nanchang 3
North Miami Beach 3
Oldenzaal 3
Reston 3
Totale 1.705
Salva come PNG Salva come JPEG
Nome #
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes, file e291c0d7-bb64-cddb-e053-3a05fe0aa144 884
The revised IPSS predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WPSS: validation by the GROM Italian regional database, file e291c0d4-7e0b-cddb-e053-3a05fe0aa144 403
Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study, file e291c0d8-744e-cddb-e053-3a05fe0aa144 226
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro, file e291c0d6-a978-cddb-e053-3a05fe0aa144 216
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications, file e291c0d6-47b5-cddb-e053-3a05fe0aa144 179
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation, file e291c0d8-5791-cddb-e053-3a05fe0aa144 169
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies, file e291c0d8-4c86-cddb-e053-3a05fe0aa144 168
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols, file af2056a3-6e4c-4bcb-a7f0-9c42270e3c53 111
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes, file e291c0d7-b022-cddb-e053-3a05fe0aa144 104
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration, file e291c0d8-c229-cddb-e053-3a05fe0aa144 104
Transcriptional and metabolic dissection of ATRA-induced granulocytic differentiation in NB4 acute promyelocytic leukemia cells, file e291c0d8-a6cf-cddb-e053-3a05fe0aa144 103
Mutational landscape of patients with acute promyelocytic leukemia at diagnosis and relapse, file e291c0d8-eb55-cddb-e053-3a05fe0aa144 92
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML, file e291c0d8-d44a-cddb-e053-3a05fe0aa144 84
Diagnostic Workup of Acute Myeloid Leukemia: What Is Really Necessary? An Italian Survey, file e291c0d9-bb98-cddb-e053-3a05fe0aa144 75
Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma, file 74f64071-7412-47ae-b806-4d24c769eda4 63
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation, file e291c0d9-2a77-cddb-e053-3a05fe0aa144 62
MRD in AML: The Role of New Techniques, file e291c0d8-a47c-cddb-e053-3a05fe0aa144 60
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes, file e291c0d8-578f-cddb-e053-3a05fe0aa144 47
Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial, file e291c0d9-7de8-cddb-e053-3a05fe0aa144 42
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence, file b041043c-c43e-4191-84ee-8263ae1e05d5 40
UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia, file 83c4b9cf-7caa-4e1c-a6eb-392a23586159 39
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol, file e291c0da-0cd4-cddb-e053-3a05fe0aa144 28
PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS, file d3fe81b1-ad03-45a3-9722-29b199058870 26
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia, file 87309ec8-cd96-4e12-a781-46dcdbab408d 17
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy, file 8faa58cd-2bb7-4b8e-aca4-aee4f82bf66f 14
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia, file e291c0d8-ce77-cddb-e053-3a05fe0aa144 13
Have we reached a molecular era in myelodysplastic syndromes?, file 86328140-40e6-4cc9-8286-45fbfeb75a75 9
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide, file dee53335-1e29-4468-ac25-d6de6f925c8f 9
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia, file 438fbfd2-5023-460b-be55-15ebf00f74d8 7
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding, file 9c0eade5-d013-475d-b501-5183832f1b0c 7
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants, file 1af3ad23-4b45-4d6f-bb60-f046ebf00437 5
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression, file 21ded611-1506-454c-8c5a-5c991d18de48 4
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML, file a242b000-cde0-4b75-b758-51de98d0e0df 4
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia, file ded2ebf5-d3fd-4be7-9c05-6e6fe0490359 4
Towards a personalized preventive strategy of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an ad hoc Italian expert panel, file 76aa3cf8-0f0d-4c36-8100-8d4d2a6ca0e8 3
Demethylation and Up-Regulation of an oncogene after hypomethylating therapy, file e91a6820-d7d3-4ec2-9c4b-da4155f58c21 3
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children?, file 4670e781-678a-49ef-aa76-ae3102040a98 2
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia, file e291c0d6-cd8b-cddb-e053-3a05fe0aa144 2
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting, file e54b27c6-ef44-4af4-8c8f-d9500bfe460e 2
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways, file e9e3a3b6-8533-4ece-8d5f-4aaf880c1937 2
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients, file f257a963-96c3-476f-b438-ff203517d771 2
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria, file a0d1a114-f3aa-4f74-8235-10e82378e421 1
Impact of NPM1/FLT3-ITD genotypes defined by the2017 European LeukemiaNet in patients with acute myeloid leukemia, file e291c0d7-9e17-cddb-e053-3a05fe0aa144 1
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders, file e291c0d8-1199-cddb-e053-3a05fe0aa144 1
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia, file e291c0d8-d450-cddb-e053-3a05fe0aa144 1
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): Phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial, file e291c0d9-01ec-cddb-e053-3a05fe0aa144 1
Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C, file e291c0d9-189f-cddb-e053-3a05fe0aa144 1
Totale 3.440
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.886
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201958 0 0 0 0 0 0 0 0 0 17 22 19
2019/2020653 31 8 10 13 16 15 104 118 80 87 96 75
2020/2021708 73 71 46 59 66 83 56 46 50 73 40 45
2021/2022507 22 29 37 34 39 28 37 33 40 37 116 55
2022/2023529 34 20 94 69 20 48 55 38 35 38 45 33
2023/2024639 51 34 39 42 38 52 157 138 58 30 0 0
Totale 3.440